Does GOLIMUMAB Cause Pulmonary fibrosis? 1,306 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,306 reports of Pulmonary fibrosis have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 1.9% of all adverse event reports for GOLIMUMAB.
1,306
Reports of Pulmonary fibrosis with GOLIMUMAB
1.9%
of all GOLIMUMAB reports
617
Deaths
805
Hospitalizations
How Dangerous Is Pulmonary fibrosis From GOLIMUMAB?
Of the 1,306 reports, 617 (47.2%) resulted in death, 805 (61.6%) required hospitalization, and 695 (53.2%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 1,306 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which GOLIMUMAB Alternatives Have Lower Pulmonary fibrosis Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN